The Novartis in Society ESG Report details progress on environmental, social and governance topics and demonstrates the company's commitment in global health and corporate responsibility. Annual Reporting Suite (including Annual Report and Form 20-F) Read and download the 2020 Annual Report and Form 20-F, and access our reporting archive Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics. Explore the ESG Indices ESG Updates: Apr 28, 2021 (PDF 0.3 MB) | Jan 27, 2021 (PDF 0.5 MB) | Oct 28, 2020 (PDF 0.5 MB) | July 24, 2020 (PDF 0.6 MB
Novartis AG and its consolidated affiliates publish consolidated financial statements expressed in US dollars. Our consolidated financial statements responsive to Item 18 of this Annual Report on Form 20-F (Annual Report) are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the Internationa Financial performance in 2020 was solid despite the impact of the global pandemic. Net sales to third parties for Novartis continuing operations grew 3% in reported terms and 3% measured in constant currencies (cc), which removes the impact of exchange rate movements Annual Report 2020 I Chairman's letter The COVID-19 pandemic in 2020 created massive soci- etal, economic and healthcare challenges. Novartis took careful steps to protect our associates, maintain supplies of medicines to patients and ensure business continuity, helping us also meet the needs and interests of our healthcare partners, stakeholders and shareholders Reporting Home; Annual Review; Novartis in Society ESG Report; At a glance. About this report; 2020 highlights; ESG management targets; Our response to COVID-19; Who we are; How we create value; Message from the Chairman; Message from the CEO; Our journey to build trust with society. Maintaining strong governance; Materiality and reporting; Engaging with stakeholder Novartis Geschäftsergebnisse 1. Quartal. Erfahren Sie mehr über unsere Geschäftsergebnisse für das erste Quartal 202
To align the 2020 Novartis in Society (NiS) Report with the priority topics identified in the 2017 corporate responsibility materiality assessment, we mapped each of these topics within one or more of the relevant sections of the 2020 NiS Report Annual Report 2018-19. Annual Report (PDF 1.61 MB) Attendance Slip & Proxy Form - 2019 AGM. Attendance Slip & Proxy Form - AGM (PDF 437 KB Annual Report on Form 20-F 2020. Download; XBRL package; Half-Year Financial Report 2020. Download; At the heart of Sanofi. Integrated Report 2020. Start the experience; All financial & CSR reports. Shareholder publications. Letter to shareholders April 2021. Download ; Letter to shareholders December 2020. Download ; Letter to shareholders August 2020. Download; All shareholder publications. Agreements with Novartis in early 2021, we will channel more energy toward creating greater value in the eye care industry. Our financial performance in 2020 reflects strong commercial execution and the decisions we made to protect our associates and continue with our strategic investments. iv Alcon Annual Report 2020. Building a Strong Culture Alcon employs 23,000+ associates across 100. Novartis | Annual Report 2020 Show details. Merck | Annual Report 2020 Show details. Cooperation project. This database is a joint project between nexxar and Message Group. About this database. Our Online Report database contains more than 500 links to Annual, Integrated and Sustainability Reports available to browse in HTML. Read more . Submit Online report. Submit a new Online report.
Novartis | Annual Report 2020 Show details. Merck | Annual Report 2020 Show details. Galapagos | Annual Report 2020 Show details. Cooperation project . This database is a joint project between nexxar and Message Group. About this database. Our Online Report database contains more than 500 links to Annual, Integrated and Sustainability Reports available to browse in HTML. Read more. Submit. Novartis | Annual Report 2020 Show details. Merck | Sustainability Report 2020 Show details. Merck | Annual Report 2020 Show details. Cooperation project. This database is a joint project between nexxar and Message Group. About this database. Our Online Report database contains more than 500 links to Annual, Integrated and Sustainability Reports available to browse in HTML. Read more. Submit. Novartis | Annual Report 2020 Show details. Novabase | Annual Report 2020 Show details. Metro | Annual Report 2020 Show details. Merck | Annual Report 2020 Show details. KION Group | Annual Report 2020 Show details. Hugo Boss | Annual Report 2020 Show details. HHLA | Annual Report 2020 Show details. Helsana | Annual Report 2020 Show details . Gunnebo | Annual Report 2020 Show details. 1 2 Show. Novartis - Annual Report 2019. Swiss Biotech Report 2020. efpia - The Pharmaceutical Industry in Figures 2020. VCI - Chemiewirtschaft in Zahlen 2020. Panorama Gesundheit 2020. Benedikt Wollny Research Expert für die Finanz- und Pharmabranche in Österreich und der Schweiz Kontaktieren Sie uns.
1. Lucentis. As Roche's Lucentis faces new competition from Novartis, biosimilars are on the way. Lucentis. 2020 U.S. sales: $1.61 billion. Disease: Wet age-related macular degeneration, macular. Drittgrößtes Schweizer Unternehmen nach Marktwert (2020): Novartis. 193 Mrd. US-Dollar. Detaillierte Statistik. Größte Schweizer Unternehmen nach Marktwert 2020 . Weitere interessante Themen Verwandte Themen Nestlé. ABB Group. Novartis. Roche. Die größten Unternehmen. Größte Unternehmen Österreichs. Weitere Studien zum Thema. Cargill - 2019 Annual Report. Trafigura - Annual Report. 2020 Annual Report, pages 50-63: Opportunity and risk report 2020 Annual Report, pages 9-11: Report of the Supervisory Board CSR Report 2020, page 10: Sustainability strategy and targets 102-32 Highest governance body's role in sustainability reportin
Annual Report de. English; Français That company's merger with Sandoz in 1996 gave rise to Novartis, where he was Group Treasurer until 2007. John Manser holds MBAs from the Alexander Hamilton Institute and the University of Columbia (New York). He also holds the Swiss Federal Banking diploma. As at 31 December 2020, he was also a member of the investment committee of the University of. 2020 (1) Company location Health Care (1) Reset. Novartis | Annual Report 2020 Show details. Cooperation project. This database is a joint project between nexxar and Message Group. About this database. Our Online Report database contains more than 500 links to Annual, Integrated and Sustainability Reports available to browse in HTML. Read more. Submit Online report. Submit a new Online. View the Novartis Annual Report 2020 (SIX filing) (PDF 3.5 MB)  View the Novartis Form 20-F 2020 (SEC filing) (PDF 3.0 MB) XBRL package View the Novartis Form 20-F in XML format in line with requirements of the SEC. XBRL Package (ZIP 0.7 MB)  Novartis in Society ESG Report 2020 The Novartis in Society ESG Report details progress on environmental, social and . governance topics and. Annual Report 2020 Team Novo Nordisk, the world's first all-diabetes professional cycling team, are racing with 100 on their jersey to celebrate the 100-year anniversary of the discovery of insulin Novo Nordisk A/S - Novo Allé 1, 2880 Bagsværd, Denmark - CVR no. 2425679
Novartis | Annual Report 2020 Show details. Novabase | Annual Report 2020 Show details. Metro | Annual Report 2020 Show details. Merck | Annual Report 2020 Show details. KION Group | Annual Report 2020 Show details. Hugo Boss | Annual Report 2020 Show details. HHLA | Annual Report 2020 Show details. Helsana | Annual Report 2020 Show details. Essity | Annual and Sustainability Report 2020 Show. Novo Nordisk Annual Report 2020 accounts for our financial, social and environmental performance during the year in one integrated report. Go to the Novo Nordisk Annual Report site NOVO NORDISK HQ. Novo Nordisk A/S Novo Allé 1 2880 Bagsværd Denmark +45-4444-8888 CVR-no. 24256790. Helpful links. Patient help Suppliers help Product list Contact us Annual Report ESG reporting Follow us. Annual Report 2020. Important Notice. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site. Any. View Annual Report 2019-2020.pdf from MANAGEMENT 02 at SASTRA University, School of Law, Thanjavur. NOVARTIS INDIA LIMITED ANNUAL REPORT 2019-20 CONTENTS Letter from the Chairman 03 Letter from th
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Novartis AG Annual Report 2020 19.27MB. 09/03/2021. Financial Report 2020 1.39MB. 09/03/2021. Message from the Chairman 2020 106KB. 09/03/2021. Statement of the CEO 2020 108KB. 09/03/2021. Letter of the CFO 2020 102KB. 09/03/2021. Corporate Governance Report 2020 442KB. 09/03/2021. Remuneration Report 2020 207KB. 09/03/2021. ESG Report 2020 1.11MB. 09/03/2021. ESG Strategy 2020 3.64MB. 09/03/2021. Annual Report 2020; Historic quarterly reporting; Finance information tool; Pipeline; Diagnostics news; Sustainability download center; Dividend calendar; Total return center; Frequently asked questions; US investors; Contacts; Stronger together Innovative tests and endeavours to ensure supplies of all our products—despite COVID-19. Scroll to explore more . Contributions against COVID-19 and.
Get a detailed Sensex annual report of Novartis India on stock/share exchange market for the financial 2020 and more at Moneycontrol.co Annual Report 2020 › Overview › Report Prior to that, he worked for the global healthcare company Novartis from 1997 to 2008, including roles as CEO of Novartis Pharmaceuticals and also as CEO of Novartis Consumer Health. The target profile of the Supervisory Board can be found on QIAGEN's website, as well as in the Governance section of this Annual Report. The current composition.
Annual Report 2020 Continue to Shareholder Letter. Satya Nadella. Chief Executive Officer. Dear shareholders, colleagues, customers, and partners: While the start of a new decade typically brings hope, we quickly saw the world come to a near standstill in 2020, confronted by compounding crises: a public health and economic crisis, persistent issues of systemic racial injustice and inequity. Novartis South Africa. Homepage. Novartis Financial Results - Q1 2021. Novartis announced the company's financial results for the first quarter of 2021. Read More. Coronavirus disease (COVID-19) update. Read More. Our Mission and Vision. Our mission is to discover new ways to improve and extend people's lives For the companies that report in yen, Med Ad News translated U.S. dollar amounts from yen at the March 2020 rate of ¥107.6673 to $1.00, except for Chugai, Kyowa Kirin and Otsuka, whose numbers were translated at the 2019 average rate of ¥110.40 to $1.00. The top 50 companies that reported in yen were: Astellas, Chugai, Daiichi Sankyo, Eisai, Kyowa Kirin, Mitsubishi Tanabe, Ono, Otsuka. information available to the Directors on the date of this Annual Report. All expectations and targets regarding future performance should also be read together with 'Assumptions related to 2016-2020 outlook' on the inside back cover of this document. A number of adjusted measures are used to report the performance of our business. These measures are defined on page 57 and a reconciliation.
Alcon will also file its 2020 Annual Report on Form 20-F with the US Securities and Exchange Commission today, costs are expected to be incurred over the two to three-year period following the completion of the Spin-off from Novartis and primarily include costs related to IT and third party consulting fees. (4) Transformation costs, primarily related to restructuring and third party. Registration document 2020 (in French) Download. XBRL package. Annual Report on Form 20-F 2020. Download. XBRL package. Half-Year Financial Report 2020. Download. At the heart of Sanofi Annual Report 2020 Partners. Together we shape the future of healthcare scroll down Why We Believe in Partnerships. Patients are the reason we come to work each day. They inspire us in our mission to create breakthrough therapies that change lives. Developing new medicines and treatment options for humans and animals is a top priority for Boehringer Ingelheim's employees - and has been for. Semi-Annual Reports. Integrated Report 2020. Integrated Report 2019. Integrated Report 2018. Integrated Report 2017. Integrated Report 2016. Annual Report 2015. FY 2020 Financial Review EN (0.45 MB) Financial Review H1 2020 EN (2.24 MB Der OMV Geschäftsbericht 2019 - 20.000 Gründe, warum wir uns auf morgen freuen
This UnitedHealth Group's 2020 business report presents the course of business throughout the respective business year. The report complies with the disclosure requirement for corporate entities. . Students need job-ready learning, employees need effective skills for remote working, and displaced workers need to regain employment. This crisis has made clear that we need institutions to enable access to education at every stage of civic life. Leah. to 28 March 2020 covered by this report. Within the strategic report 'Our Action in Response to Covid-19' is not confined to the reporting period but we have indicated where the financial impact of these actions relates to the 2019/20 financial year. Strategic report 02 Chairman's letter 04 Chief Executive's statemen Global Head of Human Resources, Pharma, Novartis Pharma AG (2016-2020) Global Head Pharma Strategy, Novartis, Pharma AG (2019) Global Head of Human Resources, Pharma Manufacturing and Quality, Novartis Pharma AG (2014-2016) Global Head of Human Resources, Central & Eastern Europe, Novartis Pharma AG (2013-2014) VP, Human Resources Canada Pharma & Corporate HR Leader, Novartis Pharma AG Novartis is the world's second-largest pharmaceutical company by market cap in 2019. Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity
Novartis key figures 2020. Novartis key figures 2020 Qiagen annual financial report 2020. Qiagen annual financial report 2020 Walgreens' business information 2020. Walgreens' business information. The EOS 2020 Annual Review includes a progress report on our participation in the collaborative initiative Climate Action 100+, where we lead or co-lead engagement with over 30 companies. We assess the net-zero commitments made by oil and gas companies as well as the decarbonisation challenges for energy demand-side participants, as policy grinds ever tighter. In the run up to COP26, to be.
Home > About us > Annual report and CSR. Autorizzo al trattamento dei miei dati personali ai sensi del D.L. 30 giugno 2003 n. 196. Edit email address. Invalid email. Your request has been sent successfully. Authorize the processing of personal data. History; Mission and Values ; Management; B Corp and Benefit Corporation; Annual and Sustainability Report; Our affiliates; Our partners. Annual Report 2020 2020 has brought about an unprecedented level of uncertainty, with a raging global pandemic that also worsened the already challenging economic environment. People, societies and companies were required to re-invent the way they live and do business - GF was no exception Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The Anti-Parkinson Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 report has been added to ResearchAndMarkets.com's offering novartis annual report 2020  In April 2014, Novartis announced that it would acquire GlaxoSmithKline's cancer drug business for $16 billion as well as selling its vaccines business to GlaxoSmithKline for $7.1 billion. Please update this article to reflect recent events or newly available information. Alcon was listed on the SIX exchange in Switzerland and NYSE exchange in the U.S.[18.
Novartis in Society US Report 2020. Novartis is building a leading focused medicines company powered by advanced therapy platforms and data science. At the same time, we are pursuing innovative approaches to making pharmaceuticals more affordable and accessible and strengthening our communities and society. Since 2016, we have published an annual Novartis in Society US Report, which details. Conference Call 1st half 2020/2021. May 11, 2021. In connection with the publication of the Interim Report on the 1st half 2020/2021, the comments by Martina Merz, CEO and Klaus Keysberg, CFO as well as the following Q&A session are available here. Recording Conference call The configuration of your firewall may prevent you from listening
2020/01 Annual Report 2019: Brochure: 2020/01 YTD Sep 2019 overview: Presentation: 2020/01 The Octavian Seminar, Zurich, January 2020: Presentation: 2020/01 JPMorgan Healthcare Conference, San Francisco, 2020: Presentation: 2019/12 SABCS Analyst Event 2019: Presentation: 2019/12 ASH Analyst Event 2019 : Presentation: 2019/11 Jefferies 2019 London Healthcare Conference: Presentation: 2019/11. . Mar 17, 2021 . PDF Version | Back to all releases. Advancing OP-1250 in metastatic, ER+ / HER2- breast cancer Phase 1/2 clinical trial; Clinical trial agreements announced with Novartis and Pfizer to explore combination of OP-1250 with CDK4/6 inhibitors and PI3Kα inhibitor. online reports databaseThe online reports database contains links to more than 500 annual, sustainability and integrated reports of international companies Annual report 2020 ISS Global A/S Buddingevej 197 DK - 2860 Søborg Denmark CVR 21 40 83 95 Annual report 1 January - 31 December 2020 Approved at the annual general meeting On 22 April 2021 Bjørn Raasteen Chairman of the annual general meeting . OVERVIEW 2 Contents Overview 3 Key figures 4 Outlook Our performance 5 Group performance 12 Regional performance Our business 15 Our strategy 18. Annual Report 2020 - Complete version Download PDF (7.17 MB) Annual Report 2020 - Financial Statements (4.02 MB) Compensation Report 2020 Download PDF (1.93 MB) Key Figures 2020 Download PDF ( 304.30 KB) If you would like to receive our ad hoc financial announcements on a regular basis, please subscribe to our Info Service. Auditors PricewaterhouseCoopers St. Jakob-Strasse 25, CH-4052 Basel.
Annual Report and Accounts 2020 Launch in March 2021. Sustainability Report 2020. Tax Contribution Report 2019. Reporting hub; Jump to content [AK + s] Jump to navigation [AK + 3] Shell. Shell Annual Report 2020. Home; Strategic Report. Close . Chair's message; Chief Executive Officer's review; Strategy, business and market overview. Selected financial data; Who we are; What we do; Our. Quarterly Results FY2020 (April 2020-March 2021) FY2020 Earnings Results (May 11, 2021) Audio Conference Call / Webcast. 4:30pm-5:15pm JST: Presentation and Q&A Session for Media ; 6:00pm-7:15pm JST: Presentation and Q&A Session for Investors and Analysts #1; 8:00am-9:00am EDT: U.S. timezone call (Q&A Session only) for Investors and Analysts #2; Participants . Christophe Weber, President and. Latest annual report Highlights Annual Report 2020. How medicines are making an impact in the lives of patients. more. Annual Report 2020; Finance Report 2020; Roche in Brief 2020; Historic quarterly reporting. Q1 2021; FY 2020; 9M 2020; HY 2020; All; Q1 2021 Investor update. Q1 2021 Presentation. Q1 2021 Presentation with appendix . Q1 2021 Webinar replay. Full-Year 2020 Investor Update. Full.
Publication of Annual Report. 13 05 2011. Annual General Meeting. Bremen. 26 05 2011. Publication of Q1 Report. 25 08 2011. Publication of Q2 Report. 24 11 2011. Publication of Q3 Report. 01 03 2012. Annual Press Conference . 27 03 2012. Publication of Annual Report. 15 05 2012. Annual General Meeting. Bremen. 31 05 2012. Publication of Q1 Report. 29 08 2012. Publication of Q2 Report. 28 11. January 2020|2 Summary The 38th annual J.P. Morgan Healthcare Conference (JPM) took place in San Francisco, CA from January 13-16, 2020. A list of events and catalysts that were announced or updated at the conference are included in this report. Below are some key points from the company presentations. Key Takeaways - Conference Review Mega Cap Companies • GlaxoSmithKline (GSK) CEO Emma. Novartis AG 2020 Q4 - Results - Earnings Call Presentation. Tue, Jan. 26. Novartis AG (NVS) CEO Vas Narasimham Presents at 39th Annual J.P. Morgan Virtual Healthcare Conference (Transcript) Mon.
Financial Transparency Reports. #getchecked. #getchecked. Wellness Day. About us. Contact us. Careers. Job Search. Featured / Jan 28. Novartis 2020 Financial Results. Novartis announced fourth quarter and full year financial results for 2020 on January 26, 2021. Read More. Novartis launches a 'Wellness Day' scheme - Encouraging employees to check-in on their health and set new community. Roche's annual results 2020. This Roche business report presents the course of business throughout the respective business year. The 2020 report complies with the disclosure requirement for.
The first Reporting Period shall be the period between the Effective Date and December 31, 2020; the following three Reporting Periods shall align to each subsequent calendar year; and the fifth and final Reporting Period shall be the period between January 1, 2024, and the expiration of the CIA on the fifth anniversary of the Effective Date. Novartis Corporate Integrity Agreement 2 . The. Annual reports archive. This page is available in English only. Year. Form 20-F / annual report. Årsrapport. XBRL data files. 2020. Annual report 2020. Årsrapport 2020 Annual Reports. Year in Review 2020. View the Report. Download Report (Desktop) Download Report (Mobile) Previous Year in Review PDFs . Year in Review 2019 Year in Review 2018 Year in Review 2018 Year in Review 2017 Year in Review 2016 Year in Review 2015 Year in Review 2014 Year in Review 2013 Year in Review 2012 Year in Review 2011 Click here to request a hard copy of the latest Annual. Annual Report 2020. This image represents our technology and was created using real-world data. Annual Report 2020 This page provides a summary of the progress we made in 2020 against our long-term priorities of Innovation, Performance and Trust, underpinned by a continuing shift in culture. The full Annual Report or individual sections can be downloaded below. Download PDFs of the full report.
Investors Annual & Interim Reports 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 First quarter 202 .7 MB) General Accident plc - 31 December 2020 Financial Statements PDF (369 KB) Climate-related financial disclosure from our 2020 Annual Report PDF (128 KB) Climate-related financial disclosure 2020 report PDF (2.5 MB) CR KPIs and assurance statement 2020 PDF (3.4 MB) Archived reports . View by year. 2019 . Annual report and accounts 2019 PDF (4.2 MB. Top Analyst Reports for Merck, Novartis & Mondelez. Contributor. Mark Vickery Zacks Published. Mar 3, 2020 3:00PM EST. Tuesday, March 3, 2020. The Zacks Research Daily presents the best research.
2020 Annual Report Target Corporation In 2020, Target was deemed an essential business in the country's response to COVID-19. That designation stemmed from our ability to provide so much of what American families needed to weather the pandemic—from food, medicine and cleaning supplies to child-care items and equipment to work and school at home Access our latest Biocon Annual report 2020 - The IMPACT Manifesto - Touching a billion lives through affordable innovatio This is the first formal Annual Report for the Institute for Advanced Clinical Trials for Children and represents a summary of key elements of the Institute's history, with a focus on 2020. We are grateful for all the support and engagement from diverse stakeholders who have helped launch the Institute as a trusted forum to help advance drug and device development for children and a. The infokit contains all publications relevant to the annual financial statements. Annual results. 2020. 2020 2019 2018 2017 2016 2015 2014 2013 2012. Annual report part 1 - corporate brochure. EN Annual Report. Annual Report (as of financial year 2019/20: Group Management Report, financial statements, governance and compensation
476 KB. Proxy. PDF. 393.8 KB. Annual Report. PDF. 6.7 MB. * As a result of the UTX and RTN merger, RTN did not file a 2019 Annual Report or a 2020 Proxy Statement This report can help inform your engagement strategies, and gives you actionable takeaways from effectively tapping managers to uilling and reskilling your workforce. In our fourth annual survey, 6,607 professionals spanning 18 countries revealed their priorities, challenges, and inspirations. What we found will surprise you 2 2020 Annual Report Using Science to Turn Insights into Medicine Our Purpose To improve the lives of patients with cancer by creating and developing innovative and differentiated antibody products. It is our reason for being. Financial Statements Management's Review 3 2020 Annual Report / Table of Contents Table of Contents Table of Contents Our Vision By 2025, our own product has. Integrated Report 2020 Growing a climate positive food future Yara is the only truly global crop nutrition company. We are driven by knowledge, science, and a strong sense of purpose. Our crop nutrition solutions, digital capabilities and deep agronomic knowledge enable us to grow a climate positive food future
. Stichting Access to Medicine. 2020. 2020 Annual Report. PDF Format Download (opens in new window) PDF 2.85 MB. 2020 Annual Report. PDF Format Download (opens in new window) 2021 Proxy Statement. PDF Format Download (opens in new window) PDF 1.94 MB. 2021 Proxy Statement. PDF Format Download (opens in new window
I am pleased to share the Division of Enforcement's annual report for Fiscal Year 2020. And what a year it was. Like everyone, the challenges we faced - and continue to face - were unexpected and beyond imagination. In response to these extraordinary challenges, the women and men of the Enforcement Division rose to the occasion and achieved extraordinary results. In the midst of massive. Henkel AG & Co. KGaA Press kit - Henkel 2020 Annual Report & Sustainability Report
Annual Report 2019 Key Data; Magazine; Downloads; MorphoSys at a glance. Magazine. Taking big steps. MorphoSys is evolving. We talked to Chief Executive Officer Jean-Paul Kress about the challenges and opportunities facing the company. READ STORY. Transatlantic Alliance. We take a look at how MorphoSys US is preparing for the potential tafasitamab launch. Tafasitamab is MorphoSys' first. Erelzi is available in Europe, where it helped contribute to a 20% increase in revenue sales for the Sandoz unit last year, Novartis said in its annual report. Sandoz got regulatory approval in.
Annual Report 2020; Financial Report & Highlights 2020. Harry Dolstra. EBMT Treasurer Netherlands The global COVID-19 pandemic and its extensive worldwide impact has also influenced the financial situation of EBMT in 2020. After the coronavirus breakout, a contingency plan was developed to secure staff positions and strategic investments. This has allowed us to build some reserves in order to.